CA2286797C - A process for the preparation of highly pure 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione - Google Patents

A process for the preparation of highly pure 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione Download PDF

Info

Publication number
CA2286797C
CA2286797C CA002286797A CA2286797A CA2286797C CA 2286797 C CA2286797 C CA 2286797C CA 002286797 A CA002286797 A CA 002286797A CA 2286797 A CA2286797 A CA 2286797A CA 2286797 C CA2286797 C CA 2286797C
Authority
CA
Canada
Prior art keywords
water
dichloro
dione
dihydroquinoxaline
nitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002286797A
Other languages
French (fr)
Other versions
CA2286797A1 (en
Inventor
Bruce Gaede
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AbbVie Inc
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of CA2286797A1 publication Critical patent/CA2286797A1/en
Application granted granted Critical
Publication of CA2286797C publication Critical patent/CA2286797C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention provides a process for the production of highly pure 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione, wherein the crude 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione is recrystallized from solution of highly polar solvents and water.

Description

A PROCESS FOR THE PREPARATION OF HIGHLY PURE 6,7-DICHLORO-5- NI-TRO-2, 3-DIHYDROQUINOXALINE-2, 3-DIONE

Technical Field of the Invention This invention relates to a process for the purification of 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione.
Background of the Invention 6,7-Dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione (CAS
153504-81-5; ACEA-1021) has the following structure:

H
:xx ACEA 1021 is being developed as a glycine site antagonist of the N-methyl-D-aspartate receptor for the treatment of head trauma and stroke. In the course of developing a large scale synthesis of 1 a suitable procedure for purification and isolation of the product was required. Previous efforts, see, e.g., Leeson, et al, J. Med.
Chem., 1994, 37, 4053; WO 94/00124; Chem. Abstr. 1994, 121, 73906; Keana, J. F. W., et al. J. Med. Chem., 1995, 38, 4367, in this area had taken advantage of the acidity of the nitrogen protons on the electron-deficient nitroquinoxalinedione to bring the highly insoluble product into solution in aqueous sodium hydroxide as the disodium salt, thereby allowing insoluble impurities to be filtered off. Addition of acid led to precipitation of the monosodium salt, which was separated from soluble impurities by filtration, and the free product was then recovered by addition of acid. While this procedure served well on a laboratory scale, difficulty was encountered on a larger scale due to incomplete reprotonation of the insoluble monosodium salt of 1.
Furthermore, low solubility of the disodium salt required the use of very large volumes of solution and resulted in a tedious neutralization procedure requiring very precise pH control.

SU8STITUTE SHEET (RULE 26) Brief Summary of the Invention Provided is a method for producing 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione. Also provided is 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione free of sodium salt wherein the crude 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione is recrystallized from a solution of highly polar solvents and water.
Preferably, the solution is comprised of dimethylsulfoxide or dimethylformamide in water. More preferably, the solution is one part DMSO to three parts water.
Most preferably, the solution is at an elevated temperature in the range of 80 to 95 C.

Also provided is a composition of 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione produced by the process of the invention.

Brief Description of the Figures Figure 1 shows the increase in ACEA 1021 purity and decrease in impurity levels at each stage of purification.
Figure 2 shows the dependence of per cent residual DMSO on stir time and precipitation temperature at two ratios of water:DMSO.

Figure 3 shows the dependence of per cent residual DMSO on temperature and ratio of water:DMSO.

Detailed Description In one aspect, there is provided a process for purifying 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione comprising recrystallization of the crude 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione from a solution of a highly polar solvent and water wherein the ratio of solvent to water is 1:1 to 10:1.

In a further aspect, there is provided a process for obtaining purified 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione comprising:

a. filtering a solution of crude 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione in the presence of a dimethylsulfoxide and activated carbon;

2a b. combining the filtered product with water in a ratio of one part dimethylsulfoxide to one to up to ten parts water at a temperature of 0 C to 5 C for 0.5 to hours to allow the pure 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione to crystallize;

c. repeating steps (a) and (b) until a purity of at least 90 percent is achieved;
d. removing residual dimethylsulfoxide and water under vacuum.

The synthesis of 1 was essentially unchanged from that reported previously.
While previous synthesis of 1 involved nitration of quinoxalinedione with solid potassium nitrate in concentrated sulfuric acid at temperatures of 0 to 22 C for extended periods of time, see, e.g., WO 94/00124, I have discovered that the reaction proceeds more cleanly at 0-10 C, and that reaction times longer than 1 hr after addition of the potassium nitrate result in no further consumption of the starting material, but did result in degradation of the product to impurities. In order to achieve this temperature control, gradual addition of the potassium nitrate was required. This was achieved by dissolving the potassium nitrate in sulfuric acid and adding the resulting solution to the solution of the substrate in sulfuric acid.
5_ Isolation of crude I was achieved by precipitation of the product upon addition of the reaction mixture to water. This resulted in an exceptionally fine precipitate which was very difficult to filter. It was found that addition of a diatomaceous earth filter aid facilitated the filtration or centrifugation and the washing of this precipitate without introducing any impurities which would contaminate the final product. The filter aid was easily removed by filtering the solution of the crude product just prior to recrystallization Given the extreme insolubility of 1, alternative solvents were investigated with the discovery that highly polar solvents, for example dimethylsulfoxide (DMSO), dimethylformamide (DMF), dimethylacetamide (DMA), N-methylpyrrolidine (NMP), diethyl sulfoxide, and sulfolane are effective for recrystallization of 1.
Impurity removal was more efficient with DMSO, and recovery was improved by using a mixture of water and DMSO. When utilizing a mixture of solvent in water the ratio 1:1 to 10:1. The preferred ratios are from 1:4 to 1:6 water:DMSO. Crude 1 was taken up in DMSO, filtered to remove filter aid and insoluble impurities, and diluted with water until crystallization ensued.
Cooling and filtration gave purified I as a 1:1 solvate with DMSO.
In preferred embodiments the mixture is cooled to 0 to 25 C, preferably 0 to 5 C. The mixture should not be cooled to less than 0 C in order to avoid freezing the solvent. The cooling can be carried out over a period of not less than about 0.1 hour and not more than about 24 hr. The recrystallization can be repeated as often as necessary until the desired degree of purity is attained, typically twice, and this results in product purity comparable to that attained previously using acid-base partition. Attempts to remove the DMSO by heating under vacuum led to decomposition, and other methods were investigated for the final isolation of 1.
The following illustrates an embodiment of the invention and is not limiting of the specification and claims in any way. All materials are reagent grade or better and are available from SUBSTITUTE SHEET (RULE 26) _,_.. _..__ . ., ..._w....~..-._ ._.. __ _ commercial vendors (e.g., Sigma Chemical Company St. Louis, MO;
Aldrich Chemical Company, Milwaukee, WI).
5_ Exam lF e 1: Synthesis and Isolation of Crude 6,7-Dichloro-l,4-dihydro-5-nitro-quinoxaline-2,3-dione (1).
A solution of 231 g (1.0 mole) dried 6,7-dichloro-1,4-dihydro-2,3-quinoxalinedione (2)lb,c in 2160 g concentrated sulfuric acid was cooled to <5 . A solution of 126.4 g(1.25 mole) potassium nitrate in 490 g concentrated sulfuric acid was prepared and cooled to ambient temperature. The potassium nitrate was added dropwise to the vigorously stirred solution of 2 with ice-salt bath cooling at a rate such that the internal temperature of the reaction did not exceed 10 ; the addition required 18 min. Part way through the addition a precipitate formed with a slight exotherm and the mixture became very thick. The mixture was stirred at 0-5 for 1 hr and quenched by pouring into 3000 ml water with external ice-salt bath cooling at a rate such that the internal temperature of the mixture did not exceed 30 . To the slurry of yellow product was added 64 g diatomaceous earth filter aid and the product isolated by centrifugation or filtration using a filter medium coated with filter aid. The product cake was washed with water until the filtrate or centrate was colorless.

Exam in e 2: Recrystallization of Crude 1.
The crude product was taken up in 2000 g dimethylsulfoxide at 90 and filtered to remove filter aid, and the cake was washed with 500 g additional dimethylsulfoxide. The filtrate was heated to 90 and 500 ml water was added with stirring. The product began to precipitate and the mixture was cooled in an ice bath to <5 . The solid product was isolated by filtration and washed with water. If the desired degree of purity was not attained a second recrystallization was carried out from 1000 g dimethylsulfoxide and 200 ml water under the same conditions.

SUBSTITUTE SHEET (RULE 26) The purified product wet cake was taken up in 750 g dimethylsulfoxide at 90 and treated with 55 g Darco G60 charcoal 5_ for 15 min. The solution was filtered through a pad of filter aid and the cake was washed with 250 g dimethylsulfoxide. The filtrate was reheated to 90 and added to 3000 ml water at 90 with stirring. The resulting yellow slurry was stirred 30 min. at 90 , then cooled to <5 , and the solid product was isolated by filtration and washed with water. The solid was dried overnight under vacuum at 90-95 with a slow nitrogen purge.
The dried solid was a pure yellow color and contained <0.1%
dimethylsulfoxide and <0.1% water. HPLC purity was >99.5%.

Example 3: Precipitation Conditions Further investigations into precipitation conditions were carried out as follows. Solutions of 4.0 g (1) in 32.0 g dimethylsulfoxide were prepared. Solutions which were to be run at 25 were heated to dissolve the solid and cooled. The required quantities of water were measured out, and the solutions of 1 and the water were heated to the precipitation temperature. The solution of 1 was added to the water with heating or cooling as necessary to maintain the temperature within 5 . (Some heat was evolved due to mixing of the dimethylsulfoxide and water.) The precipitation was either immediately filtered or held for the required period of time at the required temperature. The solid was filtered and the filter cake washed twice with 10 ml water.
The solids were dried overnight at 90 C under vacuum with a nitrogen purge, then analyzed for residual dimethylsulfoxide.2 Decolorization and Precipitation. Pure I was a bright yellow solid, but low levels of colored impurities in the starting material led to variable color in the final product. Treatment with activated carbon in hot DMSO solution and addition of the filtered DMSO solution to hot water resulted in precipitation of purified 1 largely free of colored impurities and residual DMSO.

SUBSTITUTE SHEET (RULE 26) Conditions for Product Precipitation. Initial investigation of the precipitation showed that the ratio of water to DMSO had little 5_ effect on the level of residual DMSO in the range of 8:1 to 3:1. A
two-level experimental design with center replicates was undertaken to investigate the influence of the water:DMSO ratio, the temperature of the precipitation, and the time that the mixture was stirred after precipitation. The run order was randomized, and three center points (Runs 3, 6, and 9) were included. The results shown in Table 1 were obtained.

Table 1.
Run Number Water : DMSO Ratio Temperature ( C) Stirring Time (min.) % Residual DMSO 1 0.5 1.095 300.07 2 3.0 : 1.025 300.36 3 1.75 1.060 150.10a 4 3.0 : 1.095 0 0.13 5 0.5 1.025 00.41 6 1.75 : 1.060 15 0.16 a 7 3.0 1.025 00.22 8 0.5 : 1.095 00.21 9 1.75 1.0 60 15 0.26 a 10 0.5 : 1.0 25 30 0.46 11 3.0 : 1.0 95 30 0.04 a Average of centerpoints: 0.17; s. d.:
0.07.
The results from Table 1 are shown in Figure 2. The residual DMSO levels (vertical lines) were plotted on the Time vs.
Temperature plane at two levels of water : DMSO. Using multiple linear regression, equations were derived for % residual DMSO as a function of time and temperature at the two different levels of water : DMSO, and these equations were used to draw in the surfaces in Figure 2.
The mismatch between the actual data (vertical bars) and the surfaces was indicative of the fact that no regard was given to the significance of the variables in the regression equations. From the graph it was apparent that temperature was the most SUBSTiTUTE SHEET (RULE 26) significant variable, with water : DMSO being less important and stirring time hardly affecting the results at all.
Since the time was not significant, the results for similar runs at different times were averaged (1 and 8; 2 and 7; 4 and 11;
5 and 10; 3, 6, and 9). Plotting these points in the same manner gave the graph shown in Figure 3.
Equation (2) was used to generate the surface.
% DMSO =-0.04 W - 0.00357 T + 0.508952 (2) where W Parts Water : 1 Part DMSO and T = Temperature in C.
Agreement between the plotted function and the data was better in this graph. Temperature was the most significant determinant of residual DMSO content with the amount of water being barely significant.
Residual solvent was determined by gas chromatography.
SUBSTITUTE SHEET (RULE 26)

Claims (5)

Claims
1. A process for purifying 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione comprising recrystallization of the crude 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione from a solution of a highly polar solvent and water wherein the ratio of solvent to water is 1:1 to 10:1.
2. The process of claim 1 wherein the highly polar solvent is selected from dimethylsulfoxide and dimethylformamide.
3. The process of claim 2 wherein the solvent is dimethylsulfoxide.
4. The process of claim 3 wherein the temperature of the solution is between about 0°C and 25°C.
5. A process for obtaining purified 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione comprising:

a. filtering a solution of crude 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione in the presence of a dimethylsulfoxide and activated carbon;

b. combining the filtered product with water in a ratio of one part dimethylsulfoxide to one to up to ten parts water at a temperature of 0°C to 5°C for 0.5 to 5 hours to allow the pure 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione to crystallize;

c. repeating steps (a) and (b) until a purity of at least 90 percent is achieved;

d. removing residual dimethylsulfoxide and water under vacuum.
CA002286797A 1997-04-18 1998-04-20 A process for the preparation of highly pure 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione Expired - Fee Related CA2286797C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84447597A 1997-04-18 1997-04-18
US08/844,475 1997-04-18
PCT/US1998/007966 WO1998047878A1 (en) 1997-04-18 1998-04-20 A process for the preparation of highly pure 6,7-dichloro-5- nitro-2,3-dihydroquinoxaline-2,3-dione

Publications (2)

Publication Number Publication Date
CA2286797A1 CA2286797A1 (en) 1998-10-29
CA2286797C true CA2286797C (en) 2008-07-15

Family

ID=25292811

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002286797A Expired - Fee Related CA2286797C (en) 1997-04-18 1998-04-20 A process for the preparation of highly pure 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione

Country Status (4)

Country Link
EP (1) EP0975607A1 (en)
JP (1) JP2001522358A (en)
CA (1) CA2286797C (en)
WO (1) WO1998047878A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0303197A3 (en) 2000-07-14 2008-03-28 Allergan Inc Compositions containing alpha-2 adrenergic agonist components
DK2153819T3 (en) 2000-07-14 2012-12-03 Allergan Inc Use of a solubility enhancing component in an aqueous composition comprising brimonidine tartrate
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
AU2018284335A1 (en) 2017-06-12 2020-01-30 Glytech Llc. Treatment of depression with NMDA antagonists and D2/5HT2A or selective 5HT2A antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2313714T3 (en) * 1992-06-22 2009-03-01 The Regents Of The University Of California ANTIGONISTS OF GLYCINE RECEPTORS AND USE OF THE SAME.

Also Published As

Publication number Publication date
EP0975607A1 (en) 2000-02-02
WO1998047878A1 (en) 1998-10-29
JP2001522358A (en) 2001-11-13
CA2286797A1 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
JP3854765B2 (en) Method for purifying long-chain dicarboxylic acids
CA2286797C (en) A process for the preparation of highly pure 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione
JP2013508377A (en) Use of acetic acid / water mixed solvent to prepare low sulfate 5-sulfoisophthalic acid mono-lithium salt from 5-sulfoisophthalic acid
US3864400A (en) Production of aryl-(4,4{40 -bis-(dialkylamino)-benzhydryl)-sulfones
KR100429082B1 (en) Process for the preparation of 1,2-benzisothiazolin-3-ones
RU2104271C1 (en) Method of preparing substituted or unsubstituted 1,4- dehydro-4-oxo-2-or 3-quinolinocarboxylic acids
MXPA99009559A (en) A process for the preparation of highly pure 6,7-dichloro-5- nitro-2, 3-dihydroquinoxaline-2,3-dione
McDonald et al. Pyrazine Chemistry. II. Derivatives of 3-Hydroxypyrazionic Acid
US5786479A (en) Process for producing a 6-subsitituted 2(1H)-quinoxalinone
JP4168473B2 (en) Bis (N-substituted) phthalimide, method for producing the same, and method for producing biphenyltetracarboxylic acid
JP3486633B2 (en) Purification of 2,4&#39;-dihydroxydiphenyl sulfone
JP2007015967A (en) High purity 3,3&#39;-diamino-4,4&#39;-dihydroxydiphenyl sulfone having low metal content and method for producing the same
Moore et al. UNSYMMETRICAL PHENANTHRIDONES. I. THE SYNTHESIS OF 2-NITRO-AND OF 7-NITROPHENANTHRIDONE
Jacobs et al. ON NITRO-AND AMINOPHENOXYACETIC ACIDS.
Scott et al. CCXLV.—The condensation of aromatic o-aminosulphonic acids with iso cyanic acid
US1906581A (en) Anthraquinone derivatives and a process of preparing the same
SU1068417A1 (en) Process for preparing derivatives of 1,2-dioxo-3-chloronaphthalene or 4,5-dioxoindole
Edward et al. Preparation of mesoionic dipyrido [1, 2-a: 1', 2'-c] imidazolium-11-thiolates from the Binz-Marx reaction
JPS5949265A (en) Manufacture of organic pigment based on 4,4&#39;,7,7&#39;-tetrachlorothioindigo
JPH045252A (en) Production of 4,4&#39;-dihydroxy-3,3&#39;,5,5&#39;-tetramethyl-diphenylmethane
SU1104136A1 (en) Method of obtaining benz(g)isatin
SU569553A1 (en) Method of preparing 1,3,5-tri-formylbenzol
JPS61140578A (en) Production of 4-hydroxyphthalic acid anhydride
JP2021024814A (en) Method for producing biotin
JPH03127788A (en) New method for purifying 2,4-diamino-6-(1-piperidintyl)-pyrimidine-3-oxide

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160420